Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.85 USD | +0.34% | -8.34% | -12.59% |
Apr. 26 | S&P 500 Q1 earnings estimated growth improves; stocks up for week | RE |
Apr. 26 | Leerink Partners Cuts Price Target on Bristol-Myers Squibb to $47 From $51 | MT |
ETFs positioned on Bristol-Myers Squibb Company
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
12.97% | 215 M€ | +10.68% | - | |
4.99% | 2 M€ | -.--% | ||
4.01% | 18 M€ | +3.79% | - | |
2.63% | 23 M€ | +9.02% | - | |
2.37% | 2 M€ | -25.75% | ||
2.29% | 32 M€ | -0.28% | - | |
2.08% | 9 M€ | -.--% | - | |
1.90% | 16 M€ | -3.37% | ||
1.85% | 2 M€ | +6.77% | ||
1.43% | 5 M€ | -72.95% | - | |
1.42% | 9 M€ | -4.31% | - | |
1.37% | 26 M€ | +16.85% | - | |
1.26% | 846 M€ | +2.60% | ||
1.00% | 96 M€ | -1.45% | ||
0.99% | 10 M€ | +5.96% | ||
0.83% | 105 M€ | +6.17% | ||
0.82% | 8 M€ | +2.44% | ||
0.80% | 2,510 M€ | +12.00% | ||
0.78% | 3 M€ | +15.16% | - | |
0.78% | 13 M€ | -.--% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.59% | 90.92B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- BMY Stock
- Funds and ETFs Bristol-Myers Squibb Company